Dialysis modalities and dyslipidemia.

Attman, Per-Ola; Samuelsson, Ola; Johansson, Ann-Cathrine; Moberly, James B; Alaupovic, Petar

Attman, Per-Ola; Samuelsson, Ola; Johansson, Ann-Cathrine; Moberly, James B; Alaupovic, Petar.

Afiliación

Attman PO; Department of Nephrology, Sahlgrenska University Hospital, Göteborg, Sweden. per-ola.attman@vgregion.se

Kidney Int Suppl ; (84): S110-2, 2003 May.

Article en En | MEDLINE | ID: mdl-12694322

RESUMEN

Progressive renal failure is accompanied by dyslipidemia, which is reflected in an abnormal apolipoprotein profile. It is characterized by increased concentrations of intact and partially metabolized triglyceride-rich apoB-containing lipoproteins. They occur preferentially in very-low density lipoprotein (VLDL) and low-density lipoprotein (LDL) as a result of impaired metabolism and clearance. Hemodialysis can moderately attenuate the renal dyslipidemia. In contrast, peritoneal dialysis is associated with further aggravation, including an increase of cholesterol-rich apoB-containing lipoproteins.

Asunto(s)

Hiperlipidemias/terapia; Fallo Renal Crónico/terapia; Diálisis Peritoneal; Diálisis Renal; Humanos; Hiperlipidemias/complicaciones; Fallo Renal Crónico/complicaciones

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diálisis Renal / Diálisis Peritoneal / Hiperlipidemias / Fallo Renal Crónico Límite: Humans Idioma: En Revista: Kidney Int Suppl Año: 2003 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links